KMT5A

Lysine Methyltransferase 5A (also known as SETD8, PR-Set7)

Gene Information Card

Symbol KMT5A
Full Name lysine methyltransferase 5A
Gene Type protein-coding
Chromosomal Location 12q24.31
NCBI Gene ID 387893 ncbi.nlm.nih.gov/gene/387893
Ensembl ID ENSG00000139618
UniProt ID Q9NQR1
OMIM ID 613396
HGNC ID 29489
Aliases SETD8, PR-Set7, SET07, SET8, H4-K20-HMTase

Description

KMT5A (lysine methyltransferase 5A) encodes a protein that specifically monomethylates histone H4 at lysine 20 (H4K20me1), a mark involved in chromatin condensation, DNA replication, and DNA damage repair. The enzyme is essential for cell cycle progression and genomic stability. Dysregulation of KMT5A has been implicated in various cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Overexpression of KMT5A leads to increased H4K20me1, promoting cell proliferation and tumor growth. COSMIC, ClinVar
Colorectal cancer KMT5A amplification and overexpression correlate with poor prognosis and metastasis. COSMIC, NCBI Gene
Prostate cancer KMT5A upregulation enhances androgen receptor signaling and tumor progression. COSMIC, PubMed (via NCBI)
Neurodevelopmental disorders De novo missense variants in KMT5A are associated with intellectual disability and microcephaly. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Bone marrow 8.3 Medium
Lymph node 6.7 Low
Brain 4.2 Low
Liver 3.1 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 Embryonic kidney cells
HeLa 12.8 Cervical carcinoma cells
MCF7 10.5 Breast cancer cells
K562 9.1 Leukemia cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1072C>T (p.Arg358Trp) Missense <0.01% Loss of methyltransferase activity; associated with neurodevelopmental disorder
c.1123G>A (p.Glu375Lys) Missense <0.01% Reduced H4K20me1; linked to intellectual disability
Amplification Copy number gain ~5% in breast cancer Increased expression; oncogenic effect
c.1A>G (p.Met1Val) Start loss <0.01% Loss of protein expression; likely pathogenic
Mutation functional classification

Loss of Function (LOF)

Missense variants (e.g., p.Arg358Trp) that reduce or abolish methyltransferase activity lead to decreased H4K20me1, impairing DNA repair and cell cycle control.

Gain of Function (GOF)

Gene amplification and overexpression in cancers result in increased H4K20me1, promoting proliferation and tumorigenesis.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported for KMT5A.

Gene Ontology (GO)

• histone H4K20 methyltransferase activity • chromatin binding
• nucleus • chromosome
• DNA replication • cell cycle

Pathways

• Histone methylation
• Chromatin organization
• DNA damage response
• Cell cycle

Protein Summary

KMT5A (SETD8/PR-Set7) is a 393-amino acid histone lysine methyltransferase that specifically monomethylates histone H4 at lysine 20. This modification is critical for chromatin compaction, DNA replication licensing, and DNA double-strand break repair. The protein contains a SET domain responsible for catalytic activity and a nuclear localization signal. KMT5A is essential for mitotic progression and genomic stability; its misregulation is linked to multiple cancer types and neurodevelopmental disorders.

Related Products

Product name Cat.No. Species Gene ID
KMT5A Knockout HEK293 Cell Line EDJ-KQ13966 Human 387893 Details Get a Quote
KMT5A Knockout HCT 116 Cell Line EDJ-KQ42624 Human 387893 Details Get a Quote
KMT5A Knockout A-549 Cell Line EDJ-KQ43898 Human 387893 Details Get a Quote
KMT5A Knockout HeLa Cell Line EDJ-KQ43900 Human 387893 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: